PARP Inhibition: Elucidating Mechanisms of Resistance to Improve Therapy
Pilot Research Project
Period: 05/01/2019 – 04/30/2020
Source: Mays Cancer Center, UT Health San Antonio
Title: PARP Inhibition: Elucidating Mechanisms of Resistance to Improve Therapy
Project goal: Investigate resistance of Ewing sarcoma cells to PARP inhibition using CRISPR-Cas9 approach.
Role: Principal Investigator
Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on childhood cancer by discovering, developing, and disseminating new scientific knowledge. Our mission consists of three key areas — research, clinical, and education.
Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.